Literature DB >> 9241231

Co-packaging of non-vector RNAs generates replication-defective retroviral vector particles: a novel approach for blocking retrovirus replication.

S Joshi1, S F Ding, S E Liem.   

Abstract

A Moloney murine leukemia virus (MoMuLV)-derived packaging retroviral vector, pUCMoTN-PR3, was previously developed in which the packaging (psi) signal was cloned within the 5'-long terminal repeat (LTR) U3-r and U5 sequences. The MoTN-PR3 vector particles released from a transfected packaging cell line contain RNAs with r-psi-U5 sequences at the 5'-end and U3-r sequences at the 3'-end. Upon infection, these vector particles can efficiently transduce the neomycin phosphotransferase (neo) gene to the target cells. The structure of the proviral DNA synthesized in these cells was shown to contain modified 5'- and 3'-LTRs with U3-r-psi-U5 sequences, indicating that this vector can undergo reverse transcription and integration. Analysis of psi signal-containing RNAs revealed that in addition to vector RNA transcribed from the MoMuLV 5'-LTR promoter, readthrough neo RNA transcribed from the internal herpes simplex virus (HSV) thymidine kinase (tk) promoter and cellular RNAs transcribed from the MoMuLV 3'-LTR promoter are produced. Of these, the downstream cellular RNAs are also packaged within the vector particles. These vector particles containing the vector and non-vector RNAs carrying the MoMuLV psi signal are non-infectious. It is proposed that intracellular expression of packageable non-viral RNAs may represent an effective strategy for inhibiting animal and plant virus replication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241231      PMCID: PMC146898          DOI: 10.1093/nar/25.16.3199

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  8 in total

1.  Efficient replication, integration, and packaging of retroviral vectors with modified long terminal repeats containing the packaging signal.

Authors:  S Joshi; A Van Brunschot; I Robson; A Bernstein
Journal:  Nucleic Acids Res       Date:  1990-07-25       Impact factor: 16.971

2.  Modulation of gene expression in multiple hematopoietic cell lineages following retroviral vector gene transfer.

Authors:  M C Magli; J E Dick; D Huszar; A Bernstein; R A Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  Ordered interstrand and intrastrand DNA transfer during reverse transcription.

Authors:  A T Panganiban; D Fiore
Journal:  Science       Date:  1988-08-26       Impact factor: 47.728

4.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

5.  Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus.

Authors:  R Mann; R C Mulligan; D Baltimore
Journal:  Cell       Date:  1983-05       Impact factor: 41.582

6.  Comparative analysis of five highly conserved target sites within the HIV-1 RNA for their susceptibility to hammerhead ribozyme-mediated cleavage in vitro and in vivo.

Authors:  A Ramezani; S Joshi
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1996

7.  Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression.

Authors:  S Joshi; A Van Brunschot; S Asad; I van der Elst; S E Read; A Bernstein
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

8.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

  8 in total
  2 in total

1.  Co-packaging of sense and antisense RNAs: a novel strategy for blocking HIV-1 replication.

Authors:  S F Ding; J Noronha; S Joshi
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

2.  Potential inhibition of HIV-1 encapsidation by oligoribonucleotide-dendrimer nanoparticle complexes.

Authors:  Raveen Parboosing; Louis Chonco; Francisco Javier de la Mata; Thavendran Govender; Glenn Em Maguire; Hendrik G Kruger
Journal:  Int J Nanomedicine       Date:  2017-01-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.